E. Mufson
Physiology · 2002–2007
A researcher in the Science corpus: 6 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Physiology — 16 citations into it
- Psychiatry and Mental health — 15 citations into it
- Cognitive Neuroscience — 8 citations into it
Whom E. Mufson trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from E. Mufson's perspective
Ordered by how strongly the researchers E. Mufson trusts endorse each paper. Same corpus, a different order for every researcher.
- Neuropathological stageing of Alzheimer-related changes
- On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis. (Experimental Neurology)
- Regulation of Cell Survival by Secreted Proneurotrophins (Science)
- Mild cognitive impairment represents early-stage Alzheimer disease. (Archives of Neurology)
- Parietal cortex and attention. (Current Opinion in Neurobiology)
- Direct brain infusion of glial cell line–derived neurotrophic factor in Parkinson disease (Nature Medicine)
- Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis (Science)
- Alzheimer disease in the US population: prevalence estimates using the 2000 census. (Archives of Neurology)
- Pathoanatomy of Parkinson’s disease (Journal of Neurology)
- Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration (Acta Neuropathologica)
Their papers
- Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment (2007) — 790 citations
- Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment. (2006) — 989 citations
- Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein. (2005) — 657 citations
- A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease (2005) — 1,045 citations
- Precursor form of brain‐derived neurotrophic factor and mature brain‐derived neurotrophic factor are decreased in the pre‐clinical stages of Alzheimer's disease (2005) — 680 citations
- Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment (2002) — 689 citations